| # | Drug | Count |
|---|---|---|
| 0 | QUETIAPINE | 22 |
| 1 | METHADONE | 16 |
| 2 | CITALOPRAM | 15 |
| 3 | CITALOPRAM HYDROBROMIDE | 15 |
| 4 | URSODIOL | 14 |
| 5 | URSOSIOL | 14 |
| 6 | ARIPIPRAZOLE | 8 |
| 7 | ARIPIPRAZOLE ORAL | 8 |
| 8 | ARIPIPRAZOLE ORALLY DISINTEGRATING | 8 |
| 9 | QUETIAPINE FUMARATE | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SEROTONIN | 4 | 0.0147 |
| 1 | BUPROPION HCL ER | 1 | 0.0021 |
| 2 | SORBITOL | 1 | 0.0017 |
| 3 | FLUCYTOSINE | 1 | 0.0007 |
| 4 | URSOSIOL | 14 | 0.0007 |
| 5 | URSODIOL | 14 | 0.0006 |
| 6 | NIRSEVIMAB | 1 | 0.0006 |
| 7 | AGALSIDASE BETA | 4 | 0.0004 |
| 8 | METHADONE | 16 | 0.0004 |
| 9 | ESLICARBAZEPINE ACETATE | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 24 |
| 1 | Bile Acid [EPC] | 14 |
| 2 | Serotonin Reuptake Inhibitor [EPC] | 13 |
| 3 | Benzodiazepine [EPC] | 11 |
| 4 | Anti-epileptic Agent [EPC] | 5 |
| 5 | Mood Stabilizer [EPC] | 5 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 5 |
| 7 | Calcium [EPC] | 4 |
| 8 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 4 |
| 9 | Loop Diuretic [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Nucleoside Analog Antifungal [EPC] | 1 | 0.0007 |
| 1 | Bile Acid [EPC] | 14 | 0.0006 |
| 2 | Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] | 1 | 0.0006 |
| 3 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 4 | 0.0004 |
| 4 | Carnitine Analog [EPC] | 1 | 0.0003 |
| 5 | Neonatal Fc Receptor Blocker [EPC] | 1 | 0.0002 |
| 6 | Serotonin Reuptake Inhibitor [EPC] | 13 | 0.0001 |
| 7 | Lipid-based Polyene Antifungal [EPC] | 1 | 0.0001 |
| 8 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 1 | 0.0001 |
| 9 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 1 | 0.0001 |